BIA-ALCL is a rare and highly treatable type of lymphoma that can develop within the capsule which normally forms around the implant. BIA-ALCL occurs most frequently in patients who have breast implants with textured surfaces. The implants are used in both cosmetic breast augmentation and breast reconstruction after breast cancer surgery.

The risk of developing BIA-ALCL is estimated between 1 in 3,000 to 1 in 30,000 women with textured breast implants. When BIA-ALCL is caught early, it is usually curable.

There are many different types of breast implants manufactured and only textured implants have been reported to be associated with BIA-ALCL. There is no confirmed case of BIA-ALCL associated with smooth surface implants only.

Patients may experience enlargement of breasts due to fluid collection inside the capsule, pain and masses in breasts. Symptoms usually appear more than one year after implant surgery.

If there is symptom, patient is advised to see her doctor. An ultrasound or MRI of the breasts will be needed. Collected fluid and tissue will be biopsied and sent for further study. If BIA-ALCL is confirmed, patients will be managed by multi-disciplinary treatment team.

There is no medical agency or health ministry in the world that recommends removal of the implants if there is no symptom or diagnosis is not confirmed.

You are advised to contact your doctor if more details about BIA-ALCL is needed or you experience symptoms mentioned.